![Mitchell Fink](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mitchell Fink
Director/Board Member at Midway Pharmaceuticals, Inc.
Network origin in Mitchell Fink first degree
Entity | Entity type | Industry | |
---|---|---|---|
Midway Pharmaceuticals, Inc.
![]() Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midway Pharmaceuticals, Inc. develops non-antibiotic therapies. It capitalizes on the finding the molecular weight polymers, taken orally but not systemically absorbed, can inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut barrier function and promote gastrointestinal healing. The company was founded by John Alverdy, Eugene Chang and Elaine Petrof in 2005 and is headquartered in Spring House, PA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mitchell Fink via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Pennsylvania | College/University | Masters Business Admin | |
Funk Software, Inc.
![]() Funk Software, Inc. Packaged SoftwareTechnology Services Funk Software, Inc. develops network security products and technologies that protect the integrity of the network. Its products are interoperable with products from a broad range of security and infrastructure vendors & are in widespread use on every type of network, public and private, wired & wireless. The company was founded by Paul Funk in 1982 and is located in Cambridge, MA. | Packaged Software | Corporate Officer/Principal | |
State University of New York College at Purchase | College/University | Undergraduate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
BioGenerator (Venture Capital)
![]() BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Corporate Officer/Principal | |
Companion Pharma, Inc.
![]() Companion Pharma, Inc. Pharmaceuticals: OtherHealth Technology Companion Pharma, Inc. manufactures medicines for animals. The company was founded by Harry Arader on February 01, 2012 and is headquartered in St. Louis, MO. | Pharmaceuticals: Other | Chief Executive Officer | |
Atrin Pharmaceuticals LLC
![]() Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
RxMP Therapeutics, Inc.
![]() RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RxMP Therapeutics, Inc. develops and designs novel hemostatic agents to arrest or prevent excessive bleeding. The company is headquartered in Miami, FL. | Pharmaceuticals: Major | Chief Executive Officer | |
Virion Therapeutics LLC
![]() Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Biotechnology | Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Syantra, Inc.
![]() Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Syantra, Inc. engages in the development of cancer detection and treatment technology. It offers Syantra DX - Breast Cancer, a blood-based cancer detection assay that utilizes a novel suite of biomarkers and proprietary artificial intelligence-generated algorithms to provide a positive or negative result. The company was founded by Kristina Rinker and Kenneth Fuh and is headquartered in Calgary, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
SIRPant Immunotherapeutics, Inc.
![]() SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Biotechnology | Director/Board Member | |
Covira Surgical, Inc.
![]() Covira Surgical, Inc. Miscellaneous Commercial ServicesCommercial Services Covira Surgical, Inc. is a medical device company based in North Chicago, IL. Covira Surgical, Inc. was founded in 2018 by John Alverdy and is led by CEO Peter Farmakis. | Miscellaneous Commercial Services | Founder | |
Atrin Pharmaceuticals, Inc.
![]() Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Pharmaceuticals: Major | Director/Board Member | |
Corami LLC | Corporate Officer/Principal |
Statistics
International
United States | 22 |
Canada | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 6 |
Electronic Technology | 3 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 13 |
Founder | 7 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 3 |
President | 3 |
Most connected contacts
Insiders | |
---|---|
Rifat Pamukcu | 12 |
Harry F. Arader | 7 |
Eugene Chang | 6 |
John Alverdy | 3 |
Elaine Petrof | 1 |
- Stock Market
- Insiders
- Mitchell Fink
- Company connections